Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2006

01-02-2006 | Progress in Hematology

Low-dose cyclosporin a with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen—identical siblings: a prospective phase ii study in japanese patients

Authors: Akio Kohno, Yoshihisa Morishita, Hiroatsu Iida, Hisashi Sakamaki, Toshiya Yokozawa, Kenjiro Kitaori, Kazutaka Ozeki, Keitaro Matsuo, Hiroshi Sao

Published in: International Journal of Hematology | Issue 1/2006

Login to get access
Metadata
Title
Low-dose cyclosporin a with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen—identical siblings: a prospective phase ii study in japanese patients
Authors
Akio Kohno
Yoshihisa Morishita
Hiroatsu Iida
Hisashi Sakamaki
Toshiya Yokozawa
Kenjiro Kitaori
Kazutaka Ozeki
Keitaro Matsuo
Hiroshi Sao
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue 1/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.05171

Other articles of this Issue 1/2006

International Journal of Hematology 1/2006 Go to the issue

Case Report

Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome—overt leukemia

Case Report

Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy

Letter to the Editor

Dexamethasone reduces the risk of bortezomib-induced pulmonary complications in japanese myeloma patients

Images in Hematology

Retroperitoneal follicular dendritic cell sarcoma

OriginalPaper

Endonuclease Activation and Chromosomal DNA Fragmentation during Apoptosis in Leukemia Cells

Progress in Hematology

Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits